Brief: Merus Announces Publication Of An Abstract On Petosemtamab Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma For Plenary Session Oral Presentation At The Aacr Annual Meeting 2023 And Provides A Program And Regulatory Update

Merus NV

14/04/2023 16:11

April 14 (Reuters) - Merus NV  MRUS.O :
    * MERUS ANNOUNCES PUBLICATION OF AN ABSTRACT ON PETOSEMTAMAB
MONOTHERAPY IN PREVIOUSLY TREATED HEAD AND NECK SQUAMOUS CELL
CARCINOMA FOR PLENARY SESSION ORAL PRESENTATION AT THE AACR
ANNUAL MEETING 2023 AND PROVIDES A PROGRAM AND REGULATORY UPDATE
    * MERUS NV - END-OF-PHASE MEETING WITH U.S. FOOD & DRUG
ADMINISTRATION PROVIDES CLARITY TO POTENTIAL REGISTRATION PATH
IN HNSCC
    * MERUS NV - ROBUST 36% OVERALL RESPONSE RATE (ORR) IN 42
EVALUABLE PATIENTS

Source text for Eikon:  ID:nGNX6fm4HR 
Further company coverage:  MRUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))